Sphingolipids, which are ubiquitous components of animal membranes, are especially abundant in brain, and are important constituents of the outer leaflet of plasma membranes. In this application, studies on the mechanism involved in the stimulation of lysosomal sphingolipidhydrolases by saposins (sphingolipid activator proteins) and on the function of saposins in brain development are proposed. Saposins are small, heat-stable glycoproteins that are required by lysosomal hydrolases and are also implicated as carriers of sphingolipids in other functions such as membrane formation and modification and brain development. Four saposins (A, B, C, and D) are produced by partial proteolysis of a precursor, prosaposin. Their physiological significance is suggested by a wide tissue distribution, subcellular localization which includes nuclei, conservation during evolution, and of particular relevance to neurology the finding that they are present in highest concentration in the developing brain. Genetic deficiencies of saposins lead to profound neurological deficits. Recent advances in the molecular biology of sphingolipid metabolism, in part achieved in this laboratory, for the first time provide the opportunity to define the physiological role of saposins by examination of structure-function relationships.
Three specific aims are proposed.
Aim 1 concerns the mechanism of the stimulative effects of saposins in lysosomal sphingolipid hydrolysis. The interactions of saposins A and C with pure glucosylceramide beta- glucosidase, saposin B with pure GM1 ganglioside beta-galactosidase, and saposin D with pure sphingomyelinase will be investigated in detail with and without added respective substrates and acidic lipids, such as GM1 ganglioside. Gel filtration and affinity chromatography will be used for this purpose. In addition, saposins will be partially modified by proteolysis, deglycosylation, or derivitization of specific amino acid moieties, such as cysteine, aspartic acid, glutamic acid, and lysine. These fragments or derivatives will be tested for stimulation of specific enzyme activity to obtain further insight into the structure-function relationship of saposins.
In Aim 2, the significance and function of saposins and prosaposin during development of nervous system will be investigated. Changes in amount, distribution, and biogenesis of these proteins in various regions of rat brain during development will be investigated. Saposins, prosaposin, and their homologs will be determined by measuring stimulative activities and by crossed immunoelectrophoresis. Amounts of mRNA in these tissues will be estimated by Northern blots. Based on the report of occurrence of saposins in nuclei, the specific binding of saposins with protein/nucleic acid of rat brain nuclei will be investigated by using radioactive saposins and immobilized saposins.
In Aim 3, to determine the degree of conservation of the structure of saposins and to identify portions of the sequence important to saposin function, changes in structure of saposins will be studied by determining structures of cDNA encoding saposins in three animals of key importance from various stages of evolution.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS013559-19
Application #
3395252
Study Section
Neurology B Subcommittee 2 (NEUB)
Project Start
1991-09-25
Project End
1995-08-31
Budget Start
1993-09-01
Budget End
1994-08-31
Support Year
19
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Azuma, N; Seo, H C; Lie, O et al. (1998) Cloning, expression and map assignment of chicken prosaposin. Biochem J 330 ( Pt 1):321-7
Ho, J K; Moser, H; Kishimoto, Y et al. (1995) Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy. J Clin Invest 96:1455-63
Weiler, S; Kishimoto, Y; O'Brien, J S et al. (1995) Identification of the binding and activating sites of the sphingolipid activator protein, saposin C, with glucocerebrosidase. Protein Sci 4:756-64
O'Brien, J S; Carson, G S; Seo, H C et al. (1995) Identification of the neurotrophic factor sequence of prosaposin. FASEB J 9:681-5
Azuma, N; O'Brien, J S; Moser, H W et al. (1994) Stimulation of acid ceramidase activity by saposin D. Arch Biochem Biophys 311:354-7
Fu, Q; Carson, G S; Hiraiwa, M et al. (1994) Occurrence of prosaposin as a neuronal surface membrane component. J Mol Neurosci 5:59-67
O'Brien, J S; Carson, G S; Seo, H C et al. (1994) Identification of prosaposin as a neurotrophic factor. Proc Natl Acad Sci U S A 91:9593-6
Hiraiwa, M; Soeda, S; Martin, B M et al. (1993) The effect of carbohydrate removal on stability and activity of saposin B. Arch Biochem Biophys 303:326-31
Hiraiwa, M; O'Brien, J S; Kishimoto, Y et al. (1993) Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins). Arch Biochem Biophys 304:110-6
Ito, K; Takahashi, N; Takahashi, A et al. (1993) Structural study of the oligosaccharide moieties of sphingolipid activator proteins, saposins A, C and D obtained from the spleen of a Gaucher patient. Eur J Biochem 215:171-9

Showing the most recent 10 out of 51 publications